Simplify Logo

Full-Time

Director – Marketing Excellence

Posted on 7/15/2024

BridgeBio

BridgeBio

501-1,000 employees

Develops medicines for genetic diseases

Hardware
Biotechnology
Healthcare

Compensation Overview

$215k - $280kAnnually

+ Performance Bonus + Equity + Health Benefits

Senior, Expert

San Francisco, CA, USA

Category
General Marketing
Growth & Marketing
Required Skills
Market Research
Marketing
Requirements
  • 10+ years of commercial biotech or pharmaceutical experience, with at least six years in Marketing
  • Successful launch experience in a competitive market preferred
  • Global marketing experience preferred
  • Demonstrated ability to develop actionable insights from complex clinical data and market research
  • Strong leadership skills and ability to influence functional stakeholders to set direction, align work efforts, and ensure outstanding execution
  • Excellent oral, written, and presentation skills
  • Cardiovascular experience preferred
  • Ability to travel (~20%) is required
Responsibilities
  • The Director will also support the delivery of key brand expectations such as Brand Planning, Tactical Planning, Launch Readiness, and Quarterly Business Reviews
  • Plans, executes, and optimizes marketing strategies, collaborating across multiple regions, ensuring consistency and compliance with regulatory requirements
  • Develops and implements standardized processes and best practices, oversees the creation and review of marketing materials (MLR), and collaborates with cross-functional teams to align strategies with business goals
  • Lead commercial congress activities and logistical implementation for Acoramidis Marketing teams in collaboration with brand marketing congress channel leads, including exhibit booth design and execution, advertising, sponsorship packages, product theaters, KOL receptions, and ancillary meetings/events
  • Responsibilities include the establishment of our disease state and branded speaker's bureau, the initial identification and training of speakers
  • Uncover and address unmet needs by seeking expert insights, arranging and conducting advisory boards with cross-functional leads
  • Negotiate vendor contracts related to product and brand meeting materials and activities Develop and track metrics to measure and ensure the success of marketing/promotional programs
  • Drive innovative approaches and address untapped opportunities
  • Present business updates to the Senior Team and partner with regional teams to ensure diverse commercial insights are brought into the planning process

BridgeBio Pharma develops medicines specifically for genetic diseases, focusing on conditions with well-understood genetic causes. The company operates using a decentralized subsidiary model, where each subsidiary concentrates on creating therapies for particular diseases while sharing central resources. This structure enhances efficiency and allows for the simultaneous advancement of multiple drug programs. BridgeBio utilizes advancements in genome sequencing and molecular biology to identify and develop effective treatments. Unlike many competitors, BridgeBio emphasizes independent thinking and transparency, enabling rapid, data-driven decision-making. The company's goal is to create significant therapeutic advancements by targeting diseases at their genetic source, ultimately bringing effective treatments to market more quickly.

Company Stage

IPO

Total Funding

$6.8B

Headquarters

Palo Alto, California

Founded

2014

Growth & Insights
Headcount

6 month growth

15%

1 year growth

53%

2 year growth

56%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investments, such as the $46.84 million from Norges Bank and $200 million for the oncology spinout, indicate strong financial backing and growth potential.
  • The launch of BridgeBio Oncology Therapeutics with $200 million in funding highlights the company's commitment to advancing cancer treatments, particularly KRAS inhibitors.
  • Equity grants to new employees under the Amended and Restated 2019 Inducement Equity Plan demonstrate BridgeBio's commitment to attracting and retaining top talent.

What critics are saying

  • The competitive landscape in genetic disease therapies and oncology is intense, with numerous companies vying for market share.
  • The decentralized subsidiary model, while efficient, may lead to challenges in maintaining cohesive strategic direction and operational alignment.

What makes BridgeBio unique

  • BridgeBio's decentralized subsidiary model allows for focused and efficient drug development across multiple genetic diseases simultaneously, unlike traditional centralized biopharma companies.
  • The company's emphasis on genetic diseases with well-understood causes enables targeted and potentially more effective therapies, setting it apart from competitors with broader, less focused pipelines.
  • BridgeBio's robust pipeline of over 15 drug programs targeting 20 different genetic diseases showcases its diversified approach, reducing the traditional biopharma process timeline.
INACTIVE